Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077

Long-acting injectable PrEP could offer an alternative to daily oral PrEP, improve adherence and protection, if found acceptable, safe and effective. HPTN 077 evaluated injectable cabotegravir safety, tolerability and pharmacokinetics among HIV-uninfected males and females in sequentially-enrolled c...

Full description

Saved in:
Bibliographic Details
Published in:AIDS Behav
Main Authors: Tolley, Elizabeth E., Zangeneh, Sahar Z., Chau, Gordon, Eron, Joe, Grinsztejn, Beatriz, Humphries, Hilton, Liu, Albert, Siegel, Marc, Bertha, Maseko, Panchia, Ravindre, Li, Sue, Cottle, Leslie, Rinehart, Alex, Margolis, David, Jennings, Andrea, McCauley, Marybeth, Landovitz, Raphael J.
Format: Artigo
Language:Inglês
Published: Springer US 2020
Subjects:
Original Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7423859/
https://ncbi.nlm.nih.gov/pubmed/32052214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10461-020-02808-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items